Agent website: wellabe.com/signin
Agent Support: 800.547.2401, option 3
A big, new incentive starts soon
Agents can earn more with a new Short-term Care incentive. When they write a minimum of three qualifying applications between March 1, 2024, and June 30, 2024, agents will make:
- A $400 kicker for their first or next qualifying application
- $150 for each qualifying application.
To learn more about the new Short-term Care incentive, view this message from Kelly Rayburn, AVP National Sales and Distribution.
Even more opportunities to grab extra cash
Agents can also make more money on Wellabe’s Medicare Supplement, Hospital Indemnity, Dental, and First Diagnosis Cancer insurance through March 31, 2024. Encourage your agents to check out the Incentives page on the agent portal to stay up to date on the current incentives.
Payment methods are not updating for Wellabe health products.
Wellabe is updating the payment method options for clients enrolling in Final Expense insurance underwritten by Great Western Insurance Company beginning March 1, 2024. This update does not affect clients enrolling in Wellabe health insurance products underwritten by Medico Insurance Company, Medico Life and Health Insurance Company, or Medico Corp Life Insurance Company. Clients can continue to enroll in Wellabe’s health products using a credit card, debit card, Direct Express card, or automatic bank draft.
Upcoming Medicare Supplement rerates.
Medicare Supplement policies in Arkansas, Illinois, Iowa, and West Virginia will have rate changes beginning May 1, 2024.
Bring your questions
Agents should come prepared to this week’s Tuesday Talk session. Mike Gattorna, National Sales Distribution Manager, will be answering agents’ top questions.
Other webinars this week!
Medicare Supplement insurance: Health care coverage your clients can count on Wednesday, Feb. 28 at 11 a.m. Central time
Hospital Indemnity insurance: Protect your clients’ savings when they need it most Thursday, Feb. 29 at 2 p.m. Central time
The information on this website is for agent use only and not intended for the general public.
